A 74-year-old man with Parkinson's disease on Co-careldopa for 6 years now has peak-dose dyskinesia. Amantadine is considered. What is its primary ind...

Question

A 74-year-old man with Parkinson's disease on Co-careldopa for 6 years now has peak-dose dyskinesia. Amantadine is considered. What is its primary indication here?

Accepted Answer

Specifically to reduce levodopa-induced dyskinesia

Answer

First-line Parkinson's disease treatment

Answer

Depression in Parkinson's disease

Answer

Tremor only

Answer

Antibiotic

uk-dgm MCQ (SBA): Amantadine for Dyskinesia

A 74-year-old man with Parkinson's disease on Co-careldopa for 6 years now has peak-dose dyskinesia. Amantadine is considered. What is its primary indication here?